Beta-catenin in schizophrenia: Possibly deleterious novel mutation

Area of Science:

• Neuroscience
• Genetics
• Molecular Biology

Background:

• Schizophrenia is a complex psychiatric disorder affecting ~1% of the population, with intricate genetic underpinnings.
• Genetic factors influencing brain development and synaptic plasticity are implicated in schizophrenia pathogenesis.
• The WNT signaling pathway plays a crucial role in various biological processes, including neural development.

Purpose of the Study:

• To identify novel mutations in genes within the WNT signaling pathway associated with schizophrenia.
• To analyze the potential impact of identified genetic variants on protein function using in silico methods.

Main Methods:

• Sequencing analysis of four candidate WNT pathway genes (CTNNB1, GSK3B, WNT2B, WNT7B) in 87 schizophrenia patients.
• Comparison of identified variants against a control group of 212 healthy individuals from the same geographic region.
• In silico analysis to predict the functional consequences of discovered genetic variants on protein structure and function.

Main Results:

• Three genetic variants were identified in CTNNB1 and WNT7B, absent in healthy controls.
• A novel mutation, c.1943A>G (p.N648S), was found in the CTNNB1 gene.
• In silico analysis indicated that the p.N648S mutation in CTNNB1 likely impairs protein function.

Conclusions:

• This study reports, for the first time, mutations in CTNNB1 associated with schizophrenia.
• The novel CTNNB1 mutation (p.N648S) represents a strong candidate for a disease-associated mutation in schizophrenia.
• Further research is warranted to elucidate the role of WNT pathway genetic variations in schizophrenia etiology.